FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/14/2022 |
3. Issuer Name and Ticker or Trading Symbol
Columbia Care Inc. [ CCHW ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Shares | 827,903 | D | |
Common Shares | 14,000 | I | Held in Individual Retirement Account |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Proportionate Voting Shares | (1) | (1) | Common Shares | 746.92 | $0 | D | |
Restricted Stock Units | (2) | (2) | Common Shares | 168,089 | (3) | D | |
Restricted Stock Units | (4) | (4) | Common Shares | 108,837 | (3) | D | |
Restricted Stock Units | (5) | (5) | Common Shares | 58,560 | (3) | D | |
Restricted Stock Units | (6) | (6) | Common Shares | 328,653 | (3) | D | |
Restricted Stock Units | (7) | (7) | Common Shares | 155,751 | (3) | D | |
Performance Stock Units | (8) | 04/29/2022 | Common Shares | 217,673 | (8) | D | |
Performance Stock Units | (8) | 04/29/2024 | Common Shares | 217,673 | (8) | D |
Explanation of Responses: |
1. Each proportionate share is convertible into 100 common shares of the issuer. The proportionate voting shares vest on March 31, 2022. |
2. 672,356 restricted stock units ("RSUs") were granted on September 28, 2018, with 504,267 RSUs vesting prior to the date of this Form 3. The remaining 168,089 RSUs will vest on March 31, 2022. Settlement of vested RSUs will occur within 60 days of the applicable vesting date. |
3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
4. 435,346 restricted stock units ("RSUs") were granted on April 29, 2019, with 326,509 RSUs vesting prior to the date of this Form 3. The remaining 108,837 RSUs will vest on October 29, 2022. Settlement of vested RSUs will occur within 60 days of the applicable vesting date. |
5. 117,118 restricted stock units ("RSUs") were granted on September 30, 2019, with 58,558 vesting prior to the date of this Form 3. The remaining 58,560 RSUs vest as follows: 29,280 on April 29, 2022, and 29,280 on April 29, 2023. Settlement of vested RSUs will occur within 60 days of the applicable vesting date. |
6. 438,203 restricted stock units ("RSUs") were granted on March 31, 2020, with 109,550 vesting prior to the date of this Form 3. The remaining 328,653 RSUs vest as follows: 109,551 on March 31, 2022, March 31, 2023, and March 31, 2024. Settlement of vested RSUs will occur within 60 days of the applicable vesting date. |
7. The restricted stock units ("RSUs") were granted on March 23, 2021, and vest as follows: 38,937 on March 23, 2022; 38,938 on March 23, 2023, March 23, 2024 and March 23, 2025. Settlement of vested RSUs will occur within 60 days of the applicable vesting date. |
8. The performance stock units ("PSUs") were granted on April 29, 2019. Each PSU represents a contingent right to receive one share of the Issuer's common stock. The PSUs vest upon the issuer's common stock achieving a specified price per share. |
Remarks: |
Exhibit 24.1 Power of Attorney |
/s/ David Sirolly as attorney-in-fact for David James Hart | 02/15/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |